A novel method for the assessment of cellular composition and beta-cell viability in human islet preparations. - Test2 - elhamkhani - TriplyDB

A novel method for the assessment of cellular composition and beta-cell viability in human islet preparations.

A novel method for the assessment of cellular composition and beta-cell viability in human islet preparations.

http://www.wikidata.org/entity/Q33216707

about

The unique cytoarchitecture of human pancreatic islets has implications for islet cell function Dimethyl fumarate protects pancreatic islet cells and non-endocrine tissue in L-arginine-induced chronic pancreatitis Selectivity and specificity of small molecule fluorescent dyes/probes used for the detection of Zn2+ and Ca2+ in cells A 3D map of the islet routes throughout the healthy human pancreas.Comprehensive analysis of human pancreatic islets using flow and laser scanning cytometry beta-Cell specific cytoprotection by prolactin on human islets.Characterization of pancreatic ductal cells in human islet preparations.In situ quantitative immunoprofiling of regulatory T cells using laser scanning cytometry Prolactin supplementation to culture medium improves beta-cell survival.Nephrin is expressed on the surface of insulin vesicles and facilitates glucose-stimulated insulin release.Quantitative assessment of β-cell apoptosis and cell composition of isolated, undisrupted human islets by laser scanning cytometry.Clinical islet isolation outcomes with a highly purified neutral protease for pancreas dissociation Human islet oxygen consumption rate and DNA measurements predict diabetes reversal in nude mice.Impact of tissue volume and purification on clinical autologous islet transplantation for the treatment of chronic pancreatitis.Islet assessment for transplantation.Toll-like receptor 4 (TLR4) expression in human and murine pancreatic beta-cells affects cell viability and insulin homeostasis.The Optimization of Short-Term Hepatocyte Preservation Before Transplantation Control of insulin secretion by cholinergic signaling in the human pancreatic islet.Quantitative in situ analysis of FoxP3+ T regulatory cells on transplant tissue using laser scanning cytometry.Assessment of islet function following islet and pancreas transplantation Limitations in the Use of Fluorescein Diacetate/Propidium Iodide (FDA/PI) and Cell Permeable Nucleic Acid Stains for Viability Measurements of Isolated Islets of Langerhans A simplified approach to human islet quality assessment.Regulatory challenges in manufacturing of pancreatic islets.Overcoming the challenges now limiting islet transplantation: a sequential, integrated approach.Glutathione ethyl ester supplementation during pancreatic islet isolation improves viability and transplant outcomes in a murine marginal islet mass model Magnetic resonance imaging of mouse islet grafts labeled with novel chitosan-coated superparamagnetic iron oxide nanoparticles.Regional differences in islet distribution in the human pancreas--preferential beta-cell loss in the head region in patients with type 2 diabetes Detailed protocol for evaluation of dynamic perifusion of human islets to assess β-cell function.Lipotoxic Stress Induces Pancreatic β-Cell Apoptosis through Modulation of Bcl-2 Proteins by the Ubiquitin-Proteasome System.Hyperinsulinism and diabetes: genetic dissection of beta cell metabolism-excitation coupling in mice The effect of Nrf2 pathway activation on human pancreatic islet cells.Re-engineering islet cell transplantation.Pancreatic islet cell transplantation: update and new developments.Allogeneic islet transplantation.Islet transplantation in type 1 diabetes: ongoing challenges, refined procedures, and long-term outcome Evaluation of viable β-cell mass is useful for selecting collagenase for human islet isolation: comparison of collagenase NB1 and liberase HI Toward improving human islet isolation from younger donors: rescue purification is efficient for trapped islets.Antiproinflammatory effects of iodixanol (OptiPrep)-based density gradient purification on human islet preparations.Prediction of marginal mass required for successful islet transplantation At pharmacologically relevant concentrations intravenous iron preparations cause pancreatic beta cell death.

P2860

Q24541464-A1445AE9-0817-4CBF-BD63-536EA7061144 Q28542872-093D1945-AA6E-4FFD-BB1D-AB444D5FB215 Q30572498-27A20087-982D-4666-A4FA-E5CF4A776166 Q30666066-EDD08138-33D7-426C-804A-A7DAB09A0BC2 Q33326176-FA4C5205-8D41-409E-A175-1975BC052DF1 Q33326178-0C2F3B56-184F-4963-BB98-ADE935DB0F31 Q33367926-51820616-2B58-46B8-8E4C-75EC4E725A1D Q33413309-DBED8930-D931-4187-896D-461D2C59DFEF Q33548278-C78D4418-B7A0-4284-A9F3-7EB754D61CA7 Q33556517-A64EB432-0EB0-4794-8EA3-48A0FF97BF98 Q33653228-03200661-F1C9-47F8-95B5-4B13E56A4A5D Q33728075-F5C7F268-E92D-43F9-85B2-8F2730D8AF24 Q33803861-1254581C-2A97-460B-844E-12FA8A16C638 Q33804209-54E1AA71-2294-42F7-BC6E-40AE9CDBEB08 Q33808574-6D47750E-0350-44C6-8EFA-31A8FD8C382D Q33830986-7D7C0A15-2695-4D5B-8422-8B375E3710D6 Q33874019-A1661676-64EB-4F05-9E3B-7ABF61C73538 Q33959750-3B4F82A5-7779-4395-8AE7-F9C48E137075 Q34022412-2FE47719-C715-475E-A937-3FAE7AF91EEB Q34086645-3299EE0F-9607-49C8-8592-90F29FB0BD52 Q34096963-D099AC00-7A61-4960-867A-1EEDBECCC7A0 Q34170266-ABBF5E21-9ACC-40BE-B497-E76E2F17513D Q34281812-5A5F1531-562C-4EFB-A451-E949F38DB8D1 Q34585184-7802A8BF-5D13-4296-AC47-7B7B653C6FD5 Q34592604-81AABDC5-7FB2-4672-8344-5D97FD7D8B2D Q34712141-31EACCAC-4464-44DC-A422-B94C9B2D4B8D Q34797251-A9929894-2E59-4F35-B27D-BF1479FCE83F Q35558866-D97DDBD4-8CF4-4D0C-B6BD-13D7C87D6CCB Q35625917-4278C793-2AC9-47F5-ADE3-82B1B515E2A7 Q35632861-3CF3A25D-8B30-44A4-BE30-ED56E07B4AAF Q35674148-2B1C6867-8D31-4F62-A42A-FC623CAD53A8 Q35748517-A3609136-74A8-4ACA-A88E-E51C9D066A6A Q36955936-45D35EE0-94C6-4011-B57E-B7BB0236B612 Q36981652-C93B0B79-7A55-46D9-B546-6ECB1710B34E Q37088225-7EBAAFAD-520B-43B5-9D79-8AE8E90213DE Q37183571-6511E1F7-8928-440D-81DD-551C0A1E806A Q37183576-4D8BE99D-0A1C-4D46-B864-D170C632E4E4 Q37183811-3E0BE01C-9A49-45B3-A4F3-7524110F2D05 Q37205995-47E0442E-6D4C-4109-91F3-146BA9045174 Q37369071-6AF8D102-152F-4783-AEFD-1AC57393ED17

P2860

A novel method for the assessment of cellular composition and beta-cell viability in human islet preparations.

http://www.wikidata.org/entity/Q33216707

description

2005 nî lūn-bûn

@nan

2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

A novel method for the assessm ...... y in human islet preparations.

@ast

A novel method for the assessm ...... y in human islet preparations.

@en

type

label

A novel method for the assessm ...... y in human islet preparations.

@ast

A novel method for the assessm ...... y in human islet preparations.

@en

prefLabel

A novel method for the assessm ...... y in human islet preparations.

@ast

A novel method for the assessm ...... y in human islet preparations.

@en

P1433

Q33216707-834570A0-B87D-47BE-8784-3F8479368DC9

P1476

Q33216707-B080FA26-C671-430F-A3B7-C1F651EA4B1C

P2093

Q33216707-254EA51F-7C8C-4A4C-8CC9-1D9D088A62F9

Q33216707-280F99F1-F4AF-4BDB-BF5D-FFC4F0EE1D37

Q33216707-69DDD52F-40C7-4025-B21F-6AF828848001

Q33216707-744BDED7-BB01-42F3-990E-F3AED97B113F

Q33216707-836D31DB-4B96-437B-BEA6-010525E4F34D

Q33216707-99173C5D-94B7-45E6-B852-7CCE62290808

P2860

Q33216707-5DDD4750-05D2-45B6-A8E3-390CE7D445BF

Q33216707-688B4D63-FB84-4DE7-8165-E6F38C14C34F

Q33216707-7D4E4AEC-B8C6-43FF-9383-7B4EAC352045

Q33216707-889D84C2-9623-456B-B305-AE6EB6E6A20C

Q33216707-A895075A-D748-473E-878B-2A14C6E44E76

Q33216707-B3FA1E5B-4E57-4136-B14F-C0F782CC8B5F

Q33216707-BCDEC121-223C-4810-BC1E-8C01B799A14C

Q33216707-CE188771-8059-4A1C-A235-3B13CA8DE456

Q33216707-F72FB02C-1DEB-4E22-A282-422EBB659C56

P304

Q33216707-36E4EA78-BB5D-46DC-BCDF-3F207364DD53

P31

Q33216707-D9C4C0C3-320E-4705-AF4C-9407E7F2F38B

P356

Q33216707-49405373-F870-42AD-972B-71700499873A

P407

Q33216707-4D13470C-28B7-42FF-AB2D-2609CDDF580D

P433

Q33216707-2A4EFAB8-F188-4A0A-88E8-AADFACDB2A18

P478

Q33216707-A2D2B876-BAE6-47D2-8242-8B7D2CF056D9

P50

Q33216707-5F2A51CA-5ADB-40A8-B1C9-CD0ADCEC4186

Q33216707-BB24AA0C-6BB0-4F7E-81FB-C82FD231AAF6

Q33216707-D88CD3A7-AD5F-4592-9558-7CE940AFA193

Q33216707-E84489C0-2D20-40B7-9FC3-428392A2B28A

P577

Q33216707-5270ED4B-2A78-4097-A86E-A36968200CD2

P5875

Q33216707-DAF05740-6990-41D1-9FBD-8CB62D4298D4

P698

Q33216707-0D5BF37F-766A-495A-B84A-A2E71022C852

P356

J.1600-6143.2005.00913.X

P1433

American Journal of Transplantation

P1476

A novel method for the assessm ...... y in human islet preparations.

@en

P2093

Alejandro Caicedo

http://www.w3.org/2001/XMLSchema#string

Luca Inverardi

http://www.w3.org/2001/XMLSchema#string

Over Cabrera

http://www.w3.org/2001/XMLSchema#string

R Damaris Molano

http://www.w3.org/2001/XMLSchema#string

Shari Messinger

http://www.w3.org/2001/XMLSchema#string

Yoshikazu Kuroda

http://www.w3.org/2001/XMLSchema#string

P2860

Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen

Selected Food and Drug Administration review issues for regulation of allogeneic islets of langerhans as somatic cell therapy.

Clinical islet transplantation: advances and immunological challenges.

Antiapoptotic effect of nicorandil mediated by mitochondrial atp-sensitive potassium channels in cultured cardiac myocytes.

Continuous measurement of oxygen consumption by pancreatic islets.

Achievement of insulin independence in three consecutive type-1 diabetic patients via pancreatic islet transplantation using islets isolated at a remote islet isolation center.

Insulin independence following isolated islet transplantation and single islet infusions.

Transplantation of cultured islets from two-layer preserved pancreases in type 1 diabetes with anti-CD3 antibody.

A novel method for determination of ATP, ADP, and AMP contents of a single pancreatic islet before transplantation.

P304

1635-1645

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1600-6143.2005.00913.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Camillo Ricordi

Antonello Pileggi

Per-Olof Berggren

P577

2005-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7798028

http://www.w3.org/2001/XMLSchema#string

P698

15943621

http://www.w3.org/2001/XMLSchema#string